Florence Brunel is a Senior Research Scientist at Novo Nordisk Research Center Indianapolis. She received her MS at the Ecole Nationale Superieure de Chimie de Montpellier (1999) and her Ph.D. in Chemistry at the University of Louisville in 2003, under Prof. Arno F. Spatola. Her postdoctoral work was completed at The Scripps Research Institute in San Diego where she was a CHRP (California HIV / AIDS Research Program) and a AmFAR (American Foundation for AIDS Research) fellow under the supervison of Prof. Phil Dawson. She has worked at various biopharmaceutical companies (Amylin, Pfizer, Vertex) prior to her tenure with Novo Nordisk working with Prof. Richard DiMarchi. Her expertise in peptides resides in improving their potency, stability and duration of action, as well as synthesizing and purifying peptide-protein conjugates with the ultimate goal to develop peptide-based molecules to address unmet medical needs mainly in the metabolic area.